Margaret Fang is a clinician-investigator and the Research Director of the UCSF Division of Hospital Medicine. She also serves as the Medical Director of the UCSF Anticoagulation Clinic and the Director of the UCSF Academic Hospital Medicine Fellowship. After graduating from the Honors Program in Medical Education at Northwestern University Medical School, she completed her internal medicine residency training at the Beth Israel Deaconess Medical Center in Boston. She then obtained additional research training through a General Medicine Fellowship at the Massachusetts General Hospital and obtained a Masters of Public Health at the Harvard School of Public Health.
As a cardiovascular epidemiologist and clinical outcomes researcher, Margaret's research program focuses on how to help patients balance the benefits and harms of anticoagulants for stroke and venous thromboembolism. She is the Principal Investigator of the CVRN VTE and ALTERNATIVE Cohort Studies, cohorts of patients with venous thrombosis. She is also a core investigator in the ATRIA Study group, which investigates stroke and hemorrhage outcomes in patients with atrial fibrillation.
Margaret serves on the medical advisory boards of the National Blood Clot Alliance and the North American Thrombosis Forum, two patient-advocacy organizations dedicating to raising awareness of and improving the outcomes of people with thrombosis.